Keywords
thrombosis
comorbidities
coronavirus disease
How to Cite
Abstract
Background. The unprecedented in the history of mankind problem of COronaVIrus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), having raised a huge number of fundamental questions about the pathogenesis of pneumonia.
Aim. To analyse the features of community-acquired pneumonia in COVID-19, markers of inflammation, the impact of comorbidities, and the implications for improving diagnosis and treatment in patients with comorbidities according to the professional literature.
Materials and Methods. We analyzed the literature on community-acquired pneumonia associated with COVID-19 in comorbid conditions. The search for scientific information was carried out using the scientific databases Scopus, Pub Med, Web of Science, Google Scholar.
Results. The analysis of the literature showed that the diagnosis of community-acquired pneumonia in COVID-19 requires the use of modern polymerase chain reaction platforms to verify the SARS-CoV-2 virus, atypical bacterial pathogens, fungal flora and determine drug resistance. SARS-CoV-2 pneumonia is characterized by the development of radiological patterns that can only be detected by Computed Tomography (CT) of the chest. Digital software processing of CT images allows to determine the dynamics and stage of development of pneumonia in COVID-19, to assess the effectiveness of treatment and the presence of residual changes. Community-acquired pneumonia provokes the development of hypercoagulability, but the likelihood of developing thrombosis in pneumonia with COVID-19 is much higher, which requires additional research and medical correction.
Conclusions. The role of the outpatient stage of medical care is important in increasing patient adherence to timely diagnosis, treatment and prevention of chronic diseases, which can contribute to the benign course of community-acquired pneumonia in COVID-19 and reduces the risk of death.
Keywords: inflammatory markers, thrombosis, comorbidities, coronavirus disease.
Archived: https://doi.org/10.5281/zenodo.15170117
References
Feshchenko YI, Golubovska OA, Dziublyk AY, Gavrysyuk VK, Dziublyk YA, Liskina IV. Pulmonary disease in COVID-19. Ukrainian Pulmonology Journal. 2021;1:5-14. DOI: 10.31215/2306-4927-2021-29-1-5-14. [In Ukrainian].
Dziublyk YA. Community-acquired pneumonia and COVID-19: discussion issues. Ukrainian Pulmonology Journal. 2020;4:12-4. DOI: 10.31215/2306-4927-2020-110-4-12-14. [In Ukrainian].
Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of infection and public health. 2020;13(12):1833-9. DOI: 10.1016/j.jiph.2020.07.014. PMID: 32788073
Chaban IV, Marushchak MI. Analysis of comorbidity in community-acquired pneumonia associated with COVID-19. Bulletin of problems in biology and medicine. 2024;2(173): 288-94. DOI: 10.29254/2077-4214-2024-2-173-288-294.
Savchenko OA, Podsevahyna SL, Tkachenko OV, Myrnyi DP, Katsiuba YV, Myrna AI. Problems of antibiotic therapy in СOVID-associated hospital pneumonia. Modern medical technology. 2022;2:30-5. DOI: 10.34287/MMT.2(53).2022.6. [In Ukrainian].
Lytvyn KYu, Bilokon OO, Chemerys OL. Peculiarities of the microbial composition of sputum in hospitalized patients with coronavirus disease-19 and pneumonia in the age aspect. Infectious diseases. 2024;1(115):14-20. DOI: 10.11603/1681-2727.2024.1.14410. [In Ukrainian].
Melnyk VP, Panasiuk ОV, Sadomova-Andrianova ОV, Antoniuk IV, Sliusarchuk IO, Solonynka HY. Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings. Zaporozhye medical journal. 2021;23(3):395-401. DOI: 10.14739/2310-1210.2021.3.224926. [In Ukrainian].
Yakovenko OK, Dziublyk YA, Lynnyk МІ. Determination of dynamics and stage of development of COVID-19 pneumonia based on digital software processing of images of computed tomography of the chest. Infusion & chemotherapy. 2022;1:16-22. DOI: 10.32902/2663-0338-2022-1-16-22. [In Ukrainian].
Кonopkina LІ, Rybalka КV. Community-Acquired Pneumonia Associated with COVID-19: Diagnostic Significance of Imaging Methods (CT, LUS) and Comparative Characteristics of CT- and LUS-Patterns. Tuberculosis, Lung Diseases, HIV Infection (Ukraine). 2023;4:39-48. DOI: 10.30978/TB-2023-4-39. [In Ukrainian].
Yakovenko OK, Khanin OG, Lotysh VV, Gryf SL. Clinical features of severe COVID-19 with lethal outcome in Volyn region residents. Ukrainian Pulmonology Journal. 2021;2:16-24. DOI: 10.31215/2306-4927-2021-29-2-16-24. [In Ukrainian].
Yakovenko OK., Ignatieva VI, Gumeniuk GL, Tarasenko OR, Svyatnenko VA, Lynnyk MI. Long-term treatment outcomes in community-acquired COVID-19 viral pneumonia assessed by computed tomography data. Ukrainian Pulmonology Journal. 2022;30(2-3):37-41. DOI: 10.31215/2306-4927-2022-30-2-37-41. [In Ukrainian].
Pryshlyak OY, Hryzhak IH, Tylishchak ZR, Kobryn T.Z. COVID-19 in patients at risk of severe and complicated course. Infectious diseases. 2024;4(118):4-13. DOI: 10.11603/1681-2727.2024.4.15004. [In Ukrainian].
Loboda A, Kaldiaieva M, Klymenko N, Smiian K, Melekhovets O, Vasilyeva O, et al. Features of COVID-19 in patients with diabetes mellitus. Eastern Ukrainian Medical Journal. 2024;12(3):660-9. DOI: 10.21272/eumj.2024;12(3):660-669.
Briukhanova TO, Zagayko AL, Lytkin DV. Pathophysiological mechanisms of coronavirus disease (COVID-19) progression and fatal complications in patients with diabetes. Pathologia 2020;17(2):256-63. DOI: 10.14739/2310-1237.2020.2.212812. [In Ukrainian].
Tsyhankov KV, Shostakovych-Koretska LR, Pavlenko VM, Kuzhevsky ІV, Lohvynenko VO. Pathogenetic role of endotoxicosis in development of COVID-19 severe cases: clinical and pathomorphological research. Infectious diseases. 2022;1(107):24-39. DOI: 10.11603/1681-2727.2022.1.13016. [In Ukrainian].
Pertseva ТО, Gashynova KY, Rudakova VV, Rodionova VV, Dmytrychenko VV, Kovalenko OY, et al. Clinical and laboratory features of coronavirus disease and risk factors of lethal outcome in patients who required hospitalization during the third wave of COVID-19 in Ukraine: a single-center retrospective study. Ukrainian Pulmonology Journal. 2022;4:6-18. DOI: 10.31215/2306-4927-2022-30-4-6-18. [In Ukrainian].
Cherkaskyi VV, Riabokon OV, Riabokon YuYu. Prognostic role of demographic indicators and Charlson comorbidity index in oxygen-dependent patients with coronavirus disease (COVID-19). Pathologia. 2022;19(3):214-20. DOI: 10.14739/2310-1237.2022.3.266544.
Konopkina LI, Shchudro OO. Сardiovascular system status in patients with dyspnea after COVID-19-associated pneumonia. Ukrainian Pulmonology Journal. 2022;31(4):14-21. DOI: 10.31215/2306-4927-2023-31-4-14-21. [In Ukrainian].
Dziublyk AY. Management of COPD patients in a COVID-19 pandemic. Ukrainian Pulmonology Journal. 2020;4:6-9. DOI: 10.31215/2306-4927-2020-110-4-6-9. [In Ukrainian].
DuBuske L, Todoriko L, Koval H, Yuriev S, Semianiv І, Pashkovska N, et al. Asthma and allergy practice and COVID-19: a review. Part I. Tuberculosis, Lung Diseases, HIV Infection. 2021;2:44-51. DOI: 10.30978/TB-2021-2-44.
Lynnyk МІ, Iashyna МІ, Іgnatieva МІ, Gumeniuk GL, Opimakh SG, Polianska MA, et al. Peculiarities of viral etiology COVID-19 community aquired pneumonia in patients with bronchial asthma. Asthma and allergy. 2022;1-2:15-26. DOI: 10.31655/2307-3373-2022-1-2-15-26. [In Ukrainian].
Chaban I, Hubenko I. Analysis of cardiovascular risk components in the comorbid course of community-acquired pneumonia associated with COVID-19 and arterial hypertension. Health & Education. 2024;2:102-10. DOI: 10.32782/health-2024.2.13. [In Ukrainian].
Sokolenko MO. Impact of Comorbid Pathology and Severity of Clinical Course on Anti-infective Protection in Patients with COVID-19. Tuberculosis, Lung Diseases, HIV Infection (Ukraine). 2024;3:53-9. DOI: 10.30978/TB2024-3-53. [In Ukrainian].
Pertseva TO, Gabshidze NO. The risk factors for thrombosis in patients recovered after community acquired pneumonia associated with COVID-19. Ukrainian Pulmonology Journal. 2023;31(2):24-8. DOI: 10.31215/2306-4927-2023-31-2-24-28. [In Ukrainian].
Yurko KV, Merkulova NF, Solomennyk HO, Liesna AS, Kucheriavchen VV. Peculiarities of hemostasis disorders in patients with coronavirus infection. Infectious diseases. 2020;3(101):18-22. DOI: 10.11603/1681-2727.2020.3.11549. [In Ukrainian].
Riabokon OV, Tumanska LM, Cherkaskyi VV, Riabokon YY. Clinical and pathomorphological analysis of deaths from COVID-19 in 2020. Pathologia. 2021;18(3):269-77. DOI: 10.14739/2310-1237.2021.3.242247.
Lytvyn KY, Bilokon OO. Factors associated with variability in IL-6 levels in patients with COVID-19. Infectious diseases. 2023;2(112):9-14. DOI: 10.11603/1681-2727.2023.2.14097.
Bilokon OO, Lytvyn KY. Evaluation of the Level of Serum Interleukin-10 Depending on the Demographic and General Clinical and Laboratory Characteristics of the Coronavirus Disease-19 in Hospitalized Patients. Tuberculosis, Lung Diseases, HIV Infection (Ukraine). 2024;1:21-7. DOI: 10.30978/TB2024-1-21. [In Ukrainian].
Riabokon OV, Kuliesh IO, Bielenichev IF, Riabokon YY. Clinical-pathogenetic and prognostic value of the nitrotyrosine level in the blood serum of patients with coronavirus disease (COVID-19) with pneumonia. Pathologia. 2024;21(2):141-7. DOI: 10.14739/2310-1237.2024.2.299314.
Skakun OZ, Serediuk NM. Ferritin level predicts in-hospital mortality in hypertensive patients with COVID-19. Zaporozhye medical journal. 2023;25(1):11-5. DOI: 10.14739/2310-1210.2023.1.266424.
Cherkaskyi VV, Riabokon OV, Riabokon YY. Prognostic role of demographic indicators and Charlson comorbidity index in oxygen-dependent patients with coronavirus disease (COVID-19). Pathologia. 2022;19(3):214-20. DOI: 10.14739/2310-1237.2022.3.266544.
Andreychyn MA, Kopcha VS. Features of the course of COVID-19 in patients with chronic hepatitis B and C. Infectious diseases. 2022;3(109):31-7. DOI: 10.11603/1681-2727.2022.3.13479. [In Ukrainian].
Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World journal of gastroenterology. 2021;27(13):1296-310. DOI: 10.3748/wjg.v27.i13.1296. PMID: 33833483.
Silaghi-Dumitrescu R, Patrascu I, Lehene M, Bercea I. Comorbidities of COVID-19 patients. Medicina. 2023;59(8):1393. DOI: 10.3390/medicina59081393. PMID: 37629683.
Moskaliuk VD, Andrushchak MO, Sokolenko MO. Clinical and laboratory features of kidney inflammation in patients with COVID-19. Infectious diseases. 2022;1(107):18-23. DOI 10.11603/1681-2727.2022.1.13015. [In Ukrainian].
Detsyk OZ, Burak OL, Koltsova NI, Mytnyk ZM, Kovalchuk RY. The COVID-19 pandemic influence on the main indicators of oncological, in particular oncogynecological, morbidity and mortality in Ukraine. Art of Medicine. 2022;1(21):33-8. DOI: 10.21802/artm.2022.1.21.33. [In Ukrainian].
Chyzhova VP, Korkushko OV, Shatylo VB, Pysaruk AV, Kuznietsov VV, Skrypchenko OH, et al. Psychoemotional state and bioelectrical brain activity in patients of different ages with metabolic syndrome after COVID-19. Zaporozhye medical journal. 2023;25(3):204-14. DOI: 10.14739/2310-1210.2023.3.269483. [In Ukrainian].
Kopcha VS, Maly VP. Coronavirus disease in pregnant women. Infectious diseases. 2021;4(106):36-47. DOI 10.11603/1681-2727.2021.4.12838. [In Ukrainian].
Prosvyetov YV, Bessarabov YM, Barinov SS, Gusarova AY. COVID-19 pandemic and pregnancy. Modern medical technology. 2021;2:43-6. DOI: 10.34287/MMT.2(49).2021.7. [In Ukrainian].
Spinelli A, Jones BLH, Gandhi M. COVID-19 Outcomes and Risk Factors Among People Living with HIV. Current HIV/AIDS Reports. 2022;19:425-32. DOI:10.1007/s11904-022-00618-w. PMID: 35930187.
Chemych MD, Sosnovenko DS, Kobliuk ZV, Skrypka NV. The impact of the pandemic caused by COVID-19 on the epidemiological state of HIV infection in Ukraine. Eastern ukrainian medical journal. 2022;10(2):173-81. DOI: 10.21272/eumj.2022;10(2):173-81.
Konopkina LI, Shchudro OO. Сardiovascular system status in patients with dyspnea after COVID-19-associated pneumonia. Ukrainian Pulmonology Journal. 2022;31(4):14-21. DOI: 10.31215/2306-4927-2023-31-4-14-21. [In Ukrainian].
Lynnyk МІ, Іgnatieva VІ, Gumeniuk GL, Yakovenko OK, Svyatnenko VА. Ways of transformation of typical x-ray signs of community acquired pneumonia of viraletiology (COVID-19) according to radiomics data. Tuberculosis, Lung Diseases, HIV Infection (Ukraine). 2023;2:28-35. DOI: 10.30978/TB-2023-2-28. [In Ukrainian].
Homeliuk TM, Marushchak MI. Markers of quality of life in patients with nosocomial pneumonia caused by SARS-CoV-2. Tuberculosis, Lung Diseases, HIV Infection (Ukraine). 2023;2:44-50. DOI: 10.30978/TB-2023-2-44. [In Ukrainian].
Voloshyna OB, Kovalchuk LI, Balashova IV, Buheruk VV, Zbitnieva VO. Coronavirus disease: impact on risk and clinical course of cardiovascular diseases. Odesa Medical Journal. 2023;2(183):98-103. DOI: 10.54229/2226-2008-2023-2-18. [In Ukrainian].
Hovornyan AV, Ilashchu TO. Long-term sequelae of coronavirus disease: long COVID-19 and cardiovascular outcomes (a literature review). Zaporozhye medical journal. 2024;3(144):223-33. DOI: 10.14739/2310-1210.2024.3.292858. [In Ukrainian].
Dovgan AO, Konstantinovych TV. Peculiarities of diagnosis and treatment of patients with post-COVID-19 interstitial lung anomaly on an example of clinical cases. Ukrainian Pulmonology Journal. 2024;32(3):35-9. DOI: 10.31215/2306-4927-2024-32-3-35-39. [In Ukrainian].
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.